Yingfeng Wei

617 total citations
20 papers, 485 citations indexed

About

Yingfeng Wei is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yingfeng Wei has authored 20 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Yingfeng Wei's work include Immune Cell Function and Interaction (5 papers), Hepatitis B Virus Studies (4 papers) and Influenza Virus Research Studies (3 papers). Yingfeng Wei is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Hepatitis B Virus Studies (4 papers) and Influenza Virus Research Studies (3 papers). Yingfeng Wei collaborates with scholars based in China, Japan and United States. Yingfeng Wei's co-authors include Hongyan Diao, Jianing Chen, Guangying Cui, Chong Lu, Toshimitsu Uede, Lanjuan Li, Lin Wang, Hainv Gao, Jianqin He and Li Bai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yingfeng Wei

20 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingfeng Wei China 14 160 159 146 68 56 20 485
Audrey Beringer France 8 99 0.6× 114 0.7× 340 2.3× 33 0.5× 50 0.9× 13 634
Xiuqing Wei China 12 96 0.6× 183 1.2× 50 0.3× 28 0.4× 46 0.8× 39 395
J Schölmerich Germany 10 238 1.5× 99 0.6× 127 0.9× 39 0.6× 28 0.5× 18 683
Medha Singh United States 9 125 0.8× 76 0.5× 98 0.7× 31 0.5× 41 0.7× 23 442
Giuseppe Corritore Italy 17 92 0.6× 164 1.0× 202 1.4× 50 0.7× 12 0.2× 26 600
Jean-Michel Dayer Switzerland 8 84 0.5× 86 0.5× 265 1.8× 62 0.9× 22 0.4× 8 531
Song Su China 12 78 0.5× 239 1.5× 103 0.7× 65 1.0× 28 0.5× 19 566
Qi Miao China 13 153 1.0× 96 0.6× 49 0.3× 36 0.5× 117 2.1× 38 421
Lingqing Hu China 15 80 0.5× 208 1.3× 96 0.7× 36 0.5× 14 0.3× 24 577

Countries citing papers authored by Yingfeng Wei

Since Specialization
Citations

This map shows the geographic impact of Yingfeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingfeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingfeng Wei more than expected).

Fields of papers citing papers by Yingfeng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingfeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingfeng Wei. The network helps show where Yingfeng Wei may publish in the future.

Co-authorship network of co-authors of Yingfeng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yingfeng Wei. A scholar is included among the top collaborators of Yingfeng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingfeng Wei. Yingfeng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yingfeng, et al.. (2025). Dual‐Drug Loaded γ‐Polyglutamic Acid Hydrogel with Hydrophilic Doxorubicin and Hydrophobic Camptothecin for Enhanced Tumor Therapy. Chemistry - An Asian Journal. 20(18). e00058–e00058. 1 indexed citations
2.
Wei, Yingfeng, et al.. (2020). MicroRNA-19b-3p suppresses gastric cancer development by negatively regulating neuropilin-1. Cancer Cell International. 20(1). 193–193. 20 indexed citations
3.
Lu, Chong, Xianliang Hou, Minwei Li, et al.. (2017). Detection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitis. Scientific Reports. 7(1). 796–796. 11 indexed citations
4.
Chen, Jianing, Xianliang Hou, Hongyu Jia, et al.. (2017). Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis. Oncotarget. 8(65). 108406–108417. 6 indexed citations
5.
Wang, Lin, Yingfeng Wei, Weijia Fang, et al.. (2017). Cetuximab Enhanced the Cytotoxic Activity of Immune Cells during Treatment of Colorectal Cancer. Cellular Physiology and Biochemistry. 44(3). 1038–1050. 33 indexed citations
6.
Hou, Xianliang, Jianing Chen, Yingfeng Wei, et al.. (2017). Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients. BioMed Research International. 2017. 1–17. 15 indexed citations
7.
Chen, Jianing, Guangying Cui, Chong Lu, et al.. (2016). Severe Infection With Avian Influenza A Virus is Associated With Delayed Immune Recovery in Survivors. Medicine. 95(5). e2606–e2606. 11 indexed citations
8.
Wei, Yingfeng, Benhua Zeng, Jianing Chen, et al.. (2016). Enterogenous bacterial glycolipids are required for the generation of natural killer T cells mediated liver injury. Scientific Reports. 6(1). 36365–36365. 46 indexed citations
9.
Chen, Jianing, Guangying Cui, Yingfeng Wei, et al.. (2016). Pathophysiological role of osteopontin and angiotensin II in atherosclerosis. Biochemical and Biophysical Research Communications. 471(1). 5–9. 28 indexed citations
10.
Wei, Yingfeng, Chong Lu, Jianing Chen, et al.. (2016). High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 8(1). 70–82. 69 indexed citations
11.
Wei, Yingfeng, et al.. (2015). Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer. SHILAP Revista de lepidopterología. 4 indexed citations
12.
Zhu, Yunan, Hongyu Jia, Jianing Chen, et al.. (2015). Decreased Osteopontin Expression as a Reliable Prognostic Indicator of Improvement in Pulmonary Tuberculosis: Impact of the Level of Interferon-γ-Inducible Protein 10. Cellular Physiology and Biochemistry. 37(5). 1983–1996. 13 indexed citations
13.
Diao, Hongyan, Guangying Cui, Jianing Chen, et al.. (2015). Osteopontin promotes dendritic cell maturation and function in response to HBV antigens. Drug Design Development and Therapy. 9. 3003–3003. 20 indexed citations
14.
Cui, Guangying, Jianing Chen, Hainv Gao, et al.. (2015). Regular Exercise Enhances the Immune Response Against Microbial Antigens Through Up-Regulation of Toll-like Receptor Signaling Pathways. Cellular Physiology and Biochemistry. 37(2). 735–746. 59 indexed citations
15.
Cui, Guangying, Hongyan Diao, Yingfeng Wei, et al.. (2015). Immune influence of pregnancy on human H7N9 infection: a case report. Revista Portuguesa de Pneumologia. 21(3). 157–162. 2 indexed citations
16.
Zhu, Yunan, Yingfeng Wei, Jianing Chen, et al.. (2015). Osteopontin Exacerbates Pulmonary Damage in Influenza-Induced Lung Injury. Japanese Journal of Infectious Diseases. 68(6). 467–473. 13 indexed citations
17.
Diao, Hongyan, Jianqin He, Jianing Chen, et al.. (2014). A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment. Immunology Letters. 160(1). 65–71. 16 indexed citations
18.
Chen, Jianing, Yingfeng Wei, Jianqin He, et al.. (2014). Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota. Scientific Reports. 4(1). 7259–7259. 64 indexed citations
19.
Diao, Hongyan, Guangying Cui, Yingfeng Wei, et al.. (2014). Severe H7N9 Infection Is Associated with Decreased Antigen-Presenting Capacity of CD14+ Cells. PLoS ONE. 9(3). e92823–e92823. 31 indexed citations
20.
Wei, Yingfeng. (2013). MicroRNAs may solve the mystery of chronic hepatitis B virus infection. World Journal of Gastroenterology. 19(30). 4867–4867. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026